跳至主要内容
临床试验/CTRI/2022/03/040816
CTRI/2022/03/040816已完成不适用

Assessment of Quality of life in follow-up patients with COVID-19 pneumonia

IMS SUM hospital1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2022年3月14日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
70
试验地点
1
主要终点
Assessment of quality of life using SF-12 scale in COVID-19 pneumonia follow-up patients

研究概览

简要总结

Adult patients more than 18 years after discharge with diagnosis  of  COVID pneumonia, will be assessed about their quality of life with telephonic interview 6 months after discharge. Assessment of quality of life will be done using SF-12 scale in COVID-19 pneumonia follow-up patients. Patients who have died while during follow up at 6 months, obviously their quality of life can not be assessed which is the primary outcome. But their data and records will be kept

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Inclusion criteria 1.Patients aged more than or equal to 18 years 2.Patients discharged with diagnosis of COVID-19 pneumonia.

排除标准

  • not willing to disclose their quality of life.

结局指标

主要结局

Assessment of quality of life using SF-12 scale in COVID-19 pneumonia follow-up patients

时间窗: 3 months, 6 months, 12 months

次要结局

  • mortality rate after discharge(3month 6month 12 months)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验